Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2025)

Organogenesis Holdings has reported Other Non Operating Income over the past 9 years, most recently at -$98000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$98000.0 for Q4 2025, down 262.96% from a year ago — trailing twelve months through Dec 2025 was -$5000.0 (down 125.0% YoY), and the annual figure for FY2025 was -$5000.0, down 125.0%.
  • Other Non Operating Income for Q4 2025 was -$98000.0 at Organogenesis Holdings, down from $18000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for ORGO hit a ceiling of $73000.0 in Q2 2025 and a floor of -$98000.0 in Q4 2025.
  • Median Other Non Operating Income over the past 5 years was $5000.0 (2022), compared with a mean of $2894.7.
  • Peak annual rise in Other Non Operating Income hit 866.67% in 2023, while the deepest fall reached 516.67% in 2023.
  • Organogenesis Holdings' Other Non Operating Income stood at -$19000.0 in 2021, then skyrocketed by 131.58% to $6000.0 in 2022, then plummeted by 516.67% to -$25000.0 in 2023, then decreased by 8.0% to -$27000.0 in 2024, then tumbled by 262.96% to -$98000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$98000.0 (Q4 2025), $18000.0 (Q3 2025), and $73000.0 (Q2 2025) per Business Quant data.